Blood loss prophylaxis: Tranexamic acid is safe even in high-risk patients

Basit Öğe Kaydı
dc.authorid0000-0003-0926-3029
dc.contributor.authorAzboy, İbrahim
dc.date.accessioned2021-11-02T09:13:01Z
dc.date.available2021-11-02T09:13:01Z
dc.date.issued2021
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Ortopedi ve Travmatoloji Ana Bilim Dalı
dc.description.abstractThe study by Porter et al. is elegant and perfectly designed. This study represents a clinically relevant and timely investigation with regard to tranexamic acid (TXA) use following hip fracture. Numerous studies have demonstrated that TXA can be considered safe and efficacious for elective total joint arthroplasty. As a result, TXA usage has gained momentum in patients undergoing arthroplasty. However, the evidence of TXA’s safety in high-risk patients with hip fracture undergoing arthroplasty is controversial. This study aimed to assess whether TXA administration to high-risk patients with hip fracture requiring arthroplasty increased the risk of thrombotic complications or mortality.
dc.identifier.citationAzboy, İ. (2021). Blood loss prophylaxis: Tranexamic acid is safe even in high-risk patients. The Journal of Bone and Joint Surgery, 103, e84-e84. https://dx.doi.org/10.2106/JBJS.21.00757
dc.identifier.doi10.2106/JBJS.21.00757
dc.identifier.endpagee84
dc.identifier.issn0021-9355
dc.identifier.issn1535-1386
dc.identifier.issue20
dc.identifier.scopusqualityN/A
dc.identifier.startpagee84
dc.identifier.urihttps://dx.doi.org/10.2106/JBJS.21.00757
dc.identifier.urihttps://hdl.handle.net/20.500.12511/8542
dc.identifier.volume103
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.relation.ispartofThe Journal of Bone and Joint Surgeryen_US
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.subjectTranexamic Acid
dc.subjectHigh-Risk Patients
dc.subjectBlood Loss Prophylaxis
dc.titleBlood loss prophylaxis: Tranexamic acid is safe even in high-risk patients
dc.typeEditorial

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
Azboy-Ibrahimm-2021.pdf
Boyut:
460.61 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Diğer Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu